SCHEMBL6945084

SCHEMBL6945084

CC(C)C[C@](C(N)=O)([C@H](C/C=C/c1ccccc1)C(=O)NO)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 1/20 0.42
HTR2A P28223 3/20 0.38
CTSC P53634 1/20 0.36
MMP1 P03956 2/20 0.36
MMP2 P08253 2/20 0.36
MMP3 P08254 2/20 0.36
MMP8 P22894 2/20 0.36
MMP13 P45452 2/20 0.36
MMP9 P14780 1/20 0.36
GRIK1 P39086 2/20 0.35
GRIK2 Q13002 2/20 0.35
TP53 P04637 1/20 0.34
ELANE P08246 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC7 Q8WUI4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6942351 0.85 HTR2A (0.36) ADAM17HTR2AGRIK1GRIK2ELANE
SCHEMBL6222456 0.84 ADAM17 (0.40) ADAM17HTR2ACTSCMMP1MMP2
SCHEMBL6222466 0.84 ADAM17 (0.40) ADAM17HTR2ACTSCMMP1MMP2
SCHEMBL6222461 0.84 ADAM17 (0.40) ADAM17HTR2ACTSCMMP1MMP2
SCHEMBL7827622 0.81 ADAM17 (0.38) ADAM17HTR2ACTSCMMP1MMP2
SCHEMBL6945094 0.72 ADAM17 (0.58) ADAM17MMP1MMP2MMP3MMP8
SCHEMBL6945072 0.72 ADAM17 (0.58) ADAM17MMP1MMP2MMP3MMP8
SCHEMBL6945099 0.72 ADAM17 (0.58) ADAM17MMP1MMP2MMP3MMP8
SCHEMBL6687622 0.68 ADAM17 (0.65) ADAM17HTR2AMMP1MMP2MMP3
SCHEMBL6687619 0.68 ADAM17 (0.65) ADAM17HTR2AMMP1MMP2MMP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed